NCT06729346

Brief Summary

As every urologist does transurethral resection of bladder tumor. So there are instances in which the operating surgeon is not sure whether the normal-looking mucosa or the inflammatory changes are really benign or if we are missing the CIS/bladder cancer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

December 28, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

January 29, 2025

Status Verified

December 1, 2024

Enrollment Period

3 months

First QC Date

December 7, 2024

Last Update Submit

January 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • to prove suspicious-looking mucosa on NBI has a bladder tumor on histopathology..

    At the time of TURBT

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

any patient who presented with armed forces institute of urology with bladder tumor .

You may qualify if:

  • any patient with bladder tumor

You may not qualify if:

  • any patient whose age is less than 18 years any patient whose age is more than 75 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Armed Forces Institute of Urology

Rawalpindi, Punjab Province, 46000, Pakistan

RECRUITING

Armed Forces Institute of Urology

Rawalpindi, Punjab Province, 46020, Pakistan

RECRUITING

Study Officials

  • azmat ullah, consultant urologist

    armed forces institute of urology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

azmat ullah, consultant urologist

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant urologist

Study Record Dates

First Submitted

December 7, 2024

First Posted

December 11, 2024

Study Start

December 28, 2024

Primary Completion

March 30, 2025

Study Completion

March 30, 2025

Last Updated

January 29, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Histopathology report

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
01 January 2024 till 30 march 2024
Access Criteria
each and everyone

Locations